News & Views | Published:

STROKE

Divergent effects of lipids on stroke

Nature Medicinevolume 25pages543544 (2019) | Download Citation

A large study provides causal evidence of the opposing effects of plasma low-density lipoprotein (LDL) levels on ischemic and hemorrhagic stroke in a Chinese population and suggests there is a a net benefit associated with LDL lowering.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Feigin, V. L. et al. N. Engl. J. Med. 379, 2429–2437 (2018).

  2. 2.

    Sun, L et al. Nat. Med. https://doi.org/10.1038/s41591-019-0366-x (2019).

  3. 3.

    Di Angelantonio, E. et al. JAMA 302, 1993–2000 (2009).

  4. 4.

    Fulcher, J. et al. Lancet 385, 1397–1405 (2015).

  5. 5.

    Karatasakis, A. et al. J. Am. Heart Assoc. 6, e006910 (2017).

  6. 6.

    Hindy, G. et al. Stroke 49, 820–827 (2018).

  7. 7.

    Wang, X., Dong, Y., Qi, X., Huang, C. & Hou, L. Stroke 44, 1833–1839 (2013).

  8. 8.

    Baigent, C. et al. Lancet 376, 1670–1681 (2010).

  9. 9.

    Amarenco, P. et al. N. Engl. J. Med. 355, 549–559 (2006).

  10. 10.

    Elkind, M. S. et al. Cerebrovasc. Dis. 28, 266–275 (2009).

Download references

Author information

Affiliations

  1. Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA

    • Neal S. Parikh
    •  & Mitchell S. V. Elkind
  2. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA

    • Mitchell S. V. Elkind

Authors

  1. Search for Neal S. Parikh in:

  2. Search for Mitchell S. V. Elkind in:

Competing interests

M.S.V.E. discloses receiving personal compensation for serving as an expert witness for Merck/Organon and Auxilium; honoraria for writing chapters on stroke for UpToDate; and research support but no personal compensation for a federally funded clinical trial related to stroke prevention from both the BMS-Pfizer Alliance for Eliquis and Roche; and serving as an unpaid national board member of the American Heart Association. N.S.P. has no competing interests.

Corresponding author

Correspondence to Mitchell S. V. Elkind.

About this article

Publication history

Published

Issue Date

DOI

https://doi.org/10.1038/s41591-019-0413-7

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing